Skip to main content

Table 1 Summary of three randomized controlled trials included in the meta-analysis

From: Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis

Study Publication year Stage CT regimen CRT regimen Number of patients Median survival
Girard et al. 2010 cN2 IIIA GC VP or PC + Con RT(46Gy) 14 32 24.2
Katakami et al. 2012 pN2 IIIA DC DC + Con RT(40Gy) 28 28 29.9 39.6
Pless et al. 2015 pN2 IIIA DP DP + Seq RT(44Gy) 115 117 26.2 31.7
  1. Abbreviations: GC gemcitabine + cisplatin, DP docetaxel + cisplatin, DC docetaxel + carboplatin, VP vinorelbine + cisplatin, PC paclitaxel + carboplatin, Seq RT sequential radiochemotherapy, Con RT concomitant radiochemotherapy